Press Release

GHENT, Belgium. – March 4, 2026 – Information Mapping®, the global leader in structured documentation, will take the stage at the Emerging Technologies in Pharma & AI Summit in Vienna on March 18-19, 2026. Kim Van Den Heede, Senior Consultant with the company, will lead a session addressing the critical role of structured content in the success of enterprise AI initiatives within the pharmaceutical industry. 

The Documentation Crisis Sabotaging Pharmaceutical AI

Van Den Heede’s presentation, “The Documentation Crisis Sabotaging Pharmaceutical AI (And the Strategic AI Solution to Fix It),” will detail how inconsistent, dense, and fragmented documentation is a primary cause of AI system failure. The session will explore why many pharmaceutical companies, despite multi-billion dollar investments in AI-powered quality and automation systems, struggle to achieve their desired return on investment. 

“AI is only as good as the data it’s trained on, and for many organizations, that data is a tangled web of unstructured, unsearchable content,” said Veronique Wittebolle, COO of Information Mapping. “We’re seeing a major shift in the industry as leaders recognize that a solid information architecture isn’t just a ‘nice-to-have’—it’s the very foundation of a trustworthy and effective AI strategy. Our goal at this summit is to illuminate a clear path forward for companies to de-risk their AI investments and unlock true enterprise-scale impact.” 

Elevating Documentation to a Strategic Priority 

The presentation will reframe documentation from a tactical writing concern to a strategic, executive-level priority impacting:

• Regulatory risk and compliance
• Operational consistency and efficiency
• Workforce enablement and training
• M&A harmonization and system integration
• AI deployment, governance, and accuracy 

Batch Mapping for Legacy Documentation 

Additionally, the session will introduce Information Mapping’s AI-enabled batch mapping capability. This solution is designed to convert vast libraries of legacy documents into clean, modular, and metadata-enriched content that is optimized for AI consumption, aligning with the company’s proven Information Mapping Methodology. 

As pharmaceutical leaders gather to discuss the future of digital transformation, Information Mapping’s participation underscores the growing industry consensus that structured content is a prerequisite for successful AI adoption. 

For meeting inquiries during the Vienna summit, contact:sdewaegenaere@informationmapping.com  

About Information Mapping®  

Information Mapping® is the global leader in structured documentation, trusted by Fortune 500 companies and regulated organizations to create clear, consistent, and AI-ready documentation at scale. For over 40 years, the company has helped enterprises improve compliance, reduce costs, and increase operational efficiency through its integrated approach: research-based methodology, enabling software, training and certification programs, and AI-powered professional services.